BR112017009980A2 - ?sistema e método para prevenção de alopecia?. - Google Patents

?sistema e método para prevenção de alopecia?.

Info

Publication number
BR112017009980A2
BR112017009980A2 BR112017009980A BR112017009980A BR112017009980A2 BR 112017009980 A2 BR112017009980 A2 BR 112017009980A2 BR 112017009980 A BR112017009980 A BR 112017009980A BR 112017009980 A BR112017009980 A BR 112017009980A BR 112017009980 A2 BR112017009980 A2 BR 112017009980A2
Authority
BR
Brazil
Prior art keywords
hair
disorders
alpha
limitation
treated
Prior art date
Application number
BR112017009980A
Other languages
English (en)
Portuguese (pt)
Inventor
Mccoy John
A Goren Ofer
Original Assignee
Follea Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Follea Int filed Critical Follea Int
Publication of BR112017009980A2 publication Critical patent/BR112017009980A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112017009980A 2014-11-14 2015-11-13 ?sistema e método para prevenção de alopecia?. BR112017009980A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201462080137P 2014-11-14 2014-11-14
US201562099830P 2015-01-05 2015-01-05
US201562213355P 2015-09-02 2015-09-02
US201562221863P 2015-09-22 2015-09-22
PCT/US2015/060663 WO2016077744A1 (en) 2014-11-14 2015-11-13 System and method for preventing alopecia

Publications (1)

Publication Number Publication Date
BR112017009980A2 true BR112017009980A2 (pt) 2018-02-14

Family

ID=55955138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017009980A BR112017009980A2 (pt) 2014-11-14 2015-11-13 ?sistema e método para prevenção de alopecia?.

Country Status (11)

Country Link
US (2) US10238593B2 (cg-RX-API-DMAC7.html)
EP (1) EP3217967B1 (cg-RX-API-DMAC7.html)
JP (2) JP6829196B2 (cg-RX-API-DMAC7.html)
KR (1) KR102476626B1 (cg-RX-API-DMAC7.html)
CN (1) CN107427479B (cg-RX-API-DMAC7.html)
AU (1) AU2015346126B2 (cg-RX-API-DMAC7.html)
BR (1) BR112017009980A2 (cg-RX-API-DMAC7.html)
CA (1) CA2967375C (cg-RX-API-DMAC7.html)
ES (1) ES2761688T3 (cg-RX-API-DMAC7.html)
NZ (1) NZ731850A (cg-RX-API-DMAC7.html)
WO (1) WO2016077744A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017009980A2 (pt) 2014-11-14 2018-02-14 Follea Int ?sistema e método para prevenção de alopecia?.
WO2016201286A1 (en) 2015-06-11 2016-12-15 Applied Biology, Inc. Treatment of sexual dysfunction
KR102493627B1 (ko) * 2015-11-26 2023-01-31 코웨이 주식회사 호르데닌을 유효성분으로 함유하는 피부암 예방 또는 치료용 약학 조성물
WO2018093370A1 (en) * 2016-11-17 2018-05-24 Follea International System and method for preventing alopecia
EP3426276B1 (en) 2017-05-24 2024-01-24 Follea International Synephrine compositions
WO2019143857A1 (en) * 2018-01-17 2019-07-25 University Of Florida Research Foundation, Incorporated Betel quid cessation therapy with nicotine and pilocarpine
WO2020023084A1 (en) * 2018-07-26 2020-01-30 Applied Biology, Inc. Taar receptor agonists for the treatment of alopecia
CN115135294A (zh) * 2020-02-19 2022-09-30 株式会社资生堂 利用立毛肌细胞激活的老化改善方法
WO2024118094A1 (en) * 2022-11-29 2024-06-06 Follea International System and method for preventing alopecia
CN121190403B (zh) * 2025-09-05 2026-04-07 北京大学第三医院(北京大学第三临床医学院) 一种基于人工智能的雄激素性秃发检测方法及系统

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034109A (en) 1973-01-18 1977-07-05 Wilkinson Sword Limited Compounds having a physiological cooling effect and compositions containing them
US4853216A (en) * 1987-04-02 1989-08-01 Bristol-Myers Company Process and composition for the topical application of alpha1 adrenergic agonist for pilomotor effects
US5055456A (en) * 1989-01-27 1991-10-08 American Cyanamid Co. Anti-alopecia composition
WO1994023748A1 (en) 1993-04-08 1994-10-27 The University Of Queensland Administration of vaso-active agent and therapeutic agent
CA2154979A1 (en) 1995-07-28 1997-01-29 Kenneth T. Armstrong Topical phenylephrine preparation
US6294517B1 (en) 1996-02-02 2001-09-25 Nitromed, Inc. Compositions and kits comprising alpha-adrenergic receptor antagonists and nitric oxide donors and methods of use
US5922341A (en) 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6747008B1 (en) * 2000-06-19 2004-06-08 University Of Southern California Methods for treating and preventing alopecia
US20040198706A1 (en) 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
GB0225908D0 (en) 2002-11-06 2002-12-11 Pfizer Ltd Treatment of female sexual dysfunction
US20140011774A1 (en) * 2002-12-05 2014-01-09 University Of Tennessee Research Foundation Selective androgen receptor modulators
US6938624B2 (en) * 2003-01-30 2005-09-06 Hairlocs, Inc. Methods and devices for applying hair extensions
US20060252734A1 (en) 2004-09-08 2006-11-09 Woodward John R Methods of female sexual enhancement
EP1807087A2 (en) 2004-10-12 2007-07-18 Ernir Snorrason Inhibitors of acetylcholinesterase for treating skin diseases
US20060110415A1 (en) 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
PT2656860T (pt) * 2005-06-17 2021-07-28 Wisconsin Alumni Res Found Preparações vasoconstritoras tópicas e métodos para proteção de células durante a quimoterapia e a radioterapia do cancro
US7533676B2 (en) * 2005-07-11 2009-05-19 Aderans Holdings Co., Ltd. Do-it yourself removable/reusable non-chemical highlights and hair extensions
EP1790343A1 (en) 2005-11-11 2007-05-30 Emotional Brain B.V. Pharmaceuticals formulations and uses thereof in the treatment of female sexual dysfunction
US20090068287A1 (en) 2007-09-12 2009-03-12 Susan Welsh Novel topical formulations of flucytosine and uses thereof
PT2818184T (pt) * 2007-11-16 2019-01-28 Aclaris Therapeutics Inc Composições e métodos para o tratamento de púrpura
CN102573848A (zh) 2009-04-24 2012-07-11 济州大学校产学协力团 含有去甲加兰他敏化合物作为活性成分的用于预防和治疗脱发症的组合物
US9084891B2 (en) 2012-02-06 2015-07-21 David Aberizk Pilomotor effect stimulating device and method
JP2016047806A (ja) * 2014-08-28 2016-04-07 一丸ファルコス株式会社 フェニルエチルアミン誘導体又はシネフリン含有アデノシン三リン酸フォスファターゼ発現誘導剤
BR112017009980A2 (pt) 2014-11-14 2018-02-14 Follea Int ?sistema e método para prevenção de alopecia?.
WO2016201286A1 (en) 2015-06-11 2016-12-15 Applied Biology, Inc. Treatment of sexual dysfunction

Also Published As

Publication number Publication date
KR20170098825A (ko) 2017-08-30
US20170333316A1 (en) 2017-11-23
EP3217967A4 (en) 2018-08-15
NZ731850A (en) 2023-06-30
US10238593B2 (en) 2019-03-26
AU2015346126A1 (en) 2017-06-01
JP6829196B2 (ja) 2021-02-10
CN107427479A (zh) 2017-12-01
HK1247560A1 (zh) 2018-09-28
CA2967375C (en) 2023-08-15
CN107427479B (zh) 2021-03-30
US20170135988A1 (en) 2017-05-18
JP2017533953A (ja) 2017-11-16
ES2761688T3 (es) 2020-05-20
EP3217967B1 (en) 2019-09-18
KR102476626B1 (ko) 2022-12-09
AU2015346126B2 (en) 2020-07-30
CA2967375A1 (en) 2016-05-19
EP3217967A1 (en) 2017-09-20
WO2016077744A1 (en) 2016-05-19
JP7213216B2 (ja) 2023-01-26
JP2021020938A (ja) 2021-02-18

Similar Documents

Publication Publication Date Title
NZ731850A (en) System and method for preventing alopecia
MX2019015578A (es) Metodos para tratar la enfermedad de huntington.
MX2019015580A (es) Metodos para tratar la enfermedad de huntington.
MX2021001091A (es) Compuestos para usarse en el tratamiento o mejoramiento de la enfermedad de huntington.
MX2015012302A (es) Composiciones tópicas y métodos de tratamiento para trastornos de la piel.
WO2016172658A3 (en) Microbiome regulators and related uses thereof
BR122021018243A8 (pt) Composição tópica de baixo ph e método para aumentar a aplicação tópica de um ingrediente ativo cosmeticamente aceitável
AU2018243463A8 (en) 11,13-modified saxitoxins for the treatment of pain
MX390903B (es) Composición y método para el crecimiento del cabello.
BR112018076114A2 (pt) composições tópicas de apremilast
MX389228B (es) Composiciones para tratar el cabello.
MX2017010544A (es) Metodos y composiciones para tratar la enfermedad del ojo seco y otros trastornos del ojo.
WO2017059385A8 (en) 11,13-modified saxitoxins for the treatment of pain
EP4553065A3 (en) Novel compounds for treating mitochondrial disease
CL2019002255A1 (es) 2-heteroaril-3-oxo-2,3-dihidropiridazin-4-carboxamidas.
BR112017010720A2 (pt) gel aquoso ou alcoólico aquoso de filossilicatos sintéticos como agente de viscosidade, de efeito matificante e/ou agente homogeneizador de aplicação
BR112018012022A2 (pt) ?composição, e, método para tratamento ou redução do risco de colestase intra-hepática?
BR112013003847A2 (pt) métodos de tratar a deterioração cognitiva moderada (mci) e os distúrbios relacionados
WO2015104292A3 (en) Compounds for use in treating or preventing cancerous diseases
BR112017026535A2 (pt) composto de fórmula estrutural i, enantiômero isolado, composição farmacêutica, método para inibir atividade do transportador de monocarboxilato mct4, método para inibir seletivamente atividade do transportador de monocarboxilato mct4, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 e uso de um composto
WO2018143552A3 (ko) 탈모방지 또는 발모촉진용 주사용 조성물
BR112019006880A2 (pt) compostos e composições para tratamento de leishmaniose e métodos de diagnóstico e tratamen-to usando os mesmos
BR112016007462A2 (pt) fitonutrientes anti-inflamatórios para uso no tratamento ou prevenção de sinovite
BR112018001486A2 (pt) ?composição de limpeza em barra, processo para preparar a composição, método para reduzir atividade antimicrobiana em uma superfície e uso da composição?
BR112016029996A2 (pt) utilização cosmética, composição e método cosmético para tratar os odores corporais

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]